Literature DB >> 12514596

Local treatment of Dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit.

Tetsu Sago1, Yoshio Mori, Hisato Takagi, Hisashi Iwata, Katsutoshi Murase, Yoshiaki Kawamura, Hajime Hirose.   

Abstract

OBJECTIVE: The purpose of this study was to investigate whether or not infection of prosthetic vascular graft could be prevented with the placement of antibiotic-loaded porous apatite ceramic on the graft with bacterial contamination.
METHODS: Teicoplanin as an antibiotic was loaded into a beta-tricalcium phosphate (TCP) block of porous apatite ceramic. The activity of teicoplanin released from teicoplanin-loaded TCP was examined for 40 days at 2-day intervals. In an in vivo study, the graft was patched in the abdominal aorta of a rabbit. Two different doses of Staphylococcus aureus were applied (n = 13). Teicoplanin-loaded TCP was placed around the graft infected with S aureus (n = 6). The graft, the tissue around it, and the arterial blood were collected and cultivated 4 weeks after operation.
RESULTS: The activity of teicoplanin in the replaced saline solution was maintained for at least 40 days. Because graft infection was established in all rabbits with a dose of 2 x 10(7) colony forming units, this dose was used as the dose of S aureus in this study. Fifty-seven percent of the subjects died from the infection. When teicoplanin-loaded TCP was placed around the graft contaminated with S aureus, no rabbits died. Bacterial cultures of the graft and of tissues around it were negative in all rabbits killed 4 weeks after operation. This infection was prevented with teicoplanin-loaded TCP in all rabbits.
CONCLUSION: Teicoplanin-loaded TCP may be useful in avoiding Dacron graft infection with S aureus in rabbits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514596     DOI: 10.1067/mva.2003.105

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides.

Authors:  Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Giuseppina D'Amato; Wojciech Kamysz; Federico Mocchegiani; Valerio Sisti; Carmela Silvestri; Jerzy Łukasiak; Marco Rocchi; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Synthesis and characterization of antibacterial drug loaded β-tricalcium phosphate powders for bone engineering applications.

Authors:  Aysenur Topsakal; Nazmi Ekren; Osman Kilic; Faik N Oktar; Mahir Mahirogullari; Ozan Ozkan; Hilal Turkoglu Sasmazel; Mustafa Turk; Iuliana M Bogdan; George E Stan; Oguzhan Gunduz
Journal:  J Mater Sci Mater Med       Date:  2020-01-21       Impact factor: 3.896

3.  Biological behaviour of an endothelial cell line (HPMEC) on vascular prostheses grafted with hydroxypropylgamma-cyclodextrine (HPgamma-CD) and hydroxypropylbeta-cyclodextrine (HPbeta-CD).

Authors:  N Blanchemain; F Chai; S Haulon; V Krump-Konvalinkova; M Traisnel; M Morcellet; B Martel; C J Kirkpatrick; H F Hildebrand
Journal:  J Mater Sci Mater Med       Date:  2008-02-12       Impact factor: 3.896

4.  Efficacy of linezolid, teicoplanin, and vancomycin in prevention of an experimental polytetrafluoroethylene graft infection model caused by methicillin-resistant Staphylococcus aureus.

Authors:  Bulent Mese; Orhan Bozoglan; Serdal Elveren; Erdinc Eroglu; Mustafa Gul; Ahmet Celik; Harun Ciralik; Halil Ibrahim Yildirimdemir; Alptekin Yasim
Journal:  Med Sci Monit       Date:  2015-03-27

Review 5.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.